ATE332126T1 - Geschmacksmaskierte pharmazeutische zusammensetzungen - Google Patents

Geschmacksmaskierte pharmazeutische zusammensetzungen

Info

Publication number
ATE332126T1
ATE332126T1 AT98953209T AT98953209T ATE332126T1 AT E332126 T1 ATE332126 T1 AT E332126T1 AT 98953209 T AT98953209 T AT 98953209T AT 98953209 T AT98953209 T AT 98953209T AT E332126 T1 ATE332126 T1 AT E332126T1
Authority
AT
Austria
Prior art keywords
flavor
pharmaceutical compositions
masked pharmaceutical
masked
spheronizing
Prior art date
Application number
AT98953209T
Other languages
English (en)
Inventor
Michael Augello
Ronald S Vladyka Jr
Sheila M Dell
Original Assignee
Scherer Technologies Inc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Inc R P filed Critical Scherer Technologies Inc R P
Application granted granted Critical
Publication of ATE332126T1 publication Critical patent/ATE332126T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98953209T 1997-10-03 1998-09-30 Geschmacksmaskierte pharmazeutische zusammensetzungen ATE332126T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/942,962 US5904937A (en) 1997-10-03 1997-10-03 Taste masked pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE332126T1 true ATE332126T1 (de) 2006-07-15

Family

ID=25478887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953209T ATE332126T1 (de) 1997-10-03 1998-09-30 Geschmacksmaskierte pharmazeutische zusammensetzungen

Country Status (15)

Country Link
US (1) US5904937A (de)
EP (1) EP1027038B1 (de)
JP (2) JP2001518491A (de)
KR (1) KR100563342B1 (de)
CN (1) CN1154481C (de)
AT (1) ATE332126T1 (de)
AU (1) AU1063799A (de)
BR (1) BR9812590B1 (de)
CA (1) CA2303177C (de)
DE (1) DE69835162T2 (de)
DK (1) DK1027038T3 (de)
IL (1) IL135121A (de)
NO (1) NO20001670L (de)
PL (1) PL339568A1 (de)
WO (1) WO1999017748A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2380449A1 (en) * 1999-08-17 2001-02-22 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
IL134701A0 (en) * 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
BR0109602A (pt) 2000-03-30 2004-06-29 Bristol Myers Squibb Co Glóbulos de liberação controlada contendo estavudina
EP1252886A1 (de) * 2001-04-27 2002-10-30 Universiteit Gent Pharmazeutische Pelletformulierungen für eine kontrollierte Freisetzung
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
BR0206979A (pt) * 2001-02-05 2004-04-20 Scherer Technologies Inc R P Métodos e composições para reduzir o paladar de agentes farmaceuticamente ativos
JP2005515966A (ja) 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ， インコーポレイティド 鎮痛薬としての使用のための６−ヒドロキシ−オキシモルホンの経口投与
ES2323264T3 (es) * 2001-08-01 2009-07-10 Novartis Ag Composicion para enmascaramiento del sabor.
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
ATE534371T1 (de) * 2003-02-06 2011-12-15 Gebro Pharma Gmbh Pharmazeutische zubereitungen und verfahren zu deren herstellung
JP4643899B2 (ja) * 2003-10-20 2011-03-02 エスエス製薬株式会社 イブプロフェン含有錠剤およびその製造方法
CA2618966C (en) * 2005-08-10 2014-05-13 Shionogi & Co., Ltd. Bitterness-reducing agent
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
JP2007131561A (ja) * 2005-11-09 2007-05-31 Ss Pharmaceut Co Ltd 経口固形製剤及びその製造法
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
CN101578096A (zh) * 2006-10-10 2009-11-11 潘威斯脱药物公司 稳健的缓释制剂
EP1935405A1 (de) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Im Mund zerfallende Tabletten
CA2736119C (en) * 2008-09-04 2016-08-23 Farnam Companies, Inc. Chewable sustained release formulations
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
MY159575A (en) 2009-04-02 2017-01-13 Merck Serono Sa Dihydroorotate dehydrogenase inhibitors
US20110150993A1 (en) * 2009-12-22 2011-06-23 Fmc Corporation Fine Particle Croscarmellose and Uses Thereof
ES2806256T3 (es) * 2010-10-12 2021-02-17 Bayer Ip Gmbh Productos masticables blandos no basados en almidón
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
EP3563849A3 (de) 2012-10-25 2020-02-12 The General Hospital Corporation Kombinationstherapien zur behandlung von morbus alzheimer und verwandten erkrankungen
RS57962B1 (sr) 2013-02-25 2019-01-31 Aurigene Discovery Tech Ltd Derivati trisupstituisanog benzotriazola kao inhibitori dihidroorotat oksigenaze
EP2968569A4 (de) * 2013-03-15 2016-11-02 Argenta Mfg Ltd Kaubare formulierung
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
CN110305095A (zh) 2013-10-22 2019-10-08 综合医院公司 色甘酸衍生物以及成像和治疗的相关方法
KR20170052626A (ko) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 세균질증 치료에 사용하기 위한 세크니다졸
US11253501B2 (en) * 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
JP2019524865A (ja) 2016-08-31 2019-09-05 ザ ジェネラル ホスピタル コーポレイション 神経変性疾患と関連する神経炎症におけるマクロファージ／ミクログリア
BR112019017567A2 (pt) 2017-02-24 2020-03-24 Merck Patent Gmbh Derivados de 1,4,6-trissubstituído-2-alquil-1h-benzo[d]imidazol como inibidores da di-hidro-orotato oxigenase
HRP20211462T1 (hr) 2017-04-24 2021-12-24 Aurigene Discovery Technologies Limited Postupci uporabe za trisupstituirane derivate benzotriazola kao inhibitora dihidroorotatne oksigenaze
JP7202376B2 (ja) 2017-07-20 2023-01-11 エーゼットセラピーズ， インコーポレイテッド クロモリンナトリウムおよびイブプロフェンの粉末製剤
EP3508199A1 (de) * 2018-01-05 2019-07-10 Dompé farmaceutici S.p.A. Schnell freisetzende pharmazeutische zusammensetzungen mit ketoprofen-lysinsalz
AU2019299347A1 (en) 2018-07-02 2021-01-21 Aztherapies, Inc. Powdered formulations of cromolyn sodium and alpha-lactose
MX2021006869A (es) 2018-12-10 2021-07-02 Massachusetts Gen Hospital Esteres de cromolin y usos de los mismos.
EP3804531A1 (de) * 2019-10-11 2021-04-14 Begapinol Dr. Schmidt GmbH Granulierung von topinambur
WO2021207060A1 (en) 2020-04-06 2021-10-14 The General Hospital Corporation Methods of treatment of coronavirus-induced inflammation conditions
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
WO2022146914A1 (en) 2020-12-28 2022-07-07 The General Hospital Corporation Cromolyn derivatives and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
ES2150438T3 (es) * 1991-12-30 2000-12-01 Fmc Corp Composicion de esferonizacion a base de celulosa microcristalina.
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
JPH09501678A (ja) * 1993-08-13 1997-02-18 ベイヤー、コーポレーション かむ錠剤の芳香増進剤としての加水分解ゼラチン
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules

Also Published As

Publication number Publication date
AU1063799A (en) 1999-04-27
KR100563342B1 (ko) 2006-03-22
KR20010024375A (ko) 2001-03-26
JP2007137902A (ja) 2007-06-07
CA2303177C (en) 2005-12-06
CN1273527A (zh) 2000-11-15
JP2001518491A (ja) 2001-10-16
US5904937A (en) 1999-05-18
DE69835162D1 (de) 2006-08-17
WO1999017748A1 (en) 1999-04-15
BR9812590A (pt) 2000-08-01
PL339568A1 (en) 2000-12-18
IL135121A (en) 2005-07-25
CN1154481C (zh) 2004-06-23
IL135121A0 (en) 2001-05-20
BR9812590B1 (pt) 2009-01-13
NO20001670D0 (no) 2000-03-31
EP1027038B1 (de) 2006-07-05
DE69835162T2 (de) 2007-05-31
NO20001670L (no) 2000-05-22
CA2303177A1 (en) 1999-04-15
EP1027038A4 (de) 2005-02-09
DK1027038T3 (da) 2006-09-18
EP1027038A1 (de) 2000-08-16

Similar Documents

Publication Publication Date Title
ATE332126T1 (de) Geschmacksmaskierte pharmazeutische zusammensetzungen
NO934315D0 (no) Farmas!ytisk b{rer
DK0605497T4 (da) Lægemiddelbærer af faste lipidpartikler (faste lipidnanosfærer (SLN))
UY24888A1 (es) Tabletas de oxacarbazepina recubiertas de pelicula
ES2080796T5 (es) Formulaciones de productos farmaceuticos de liberacion prolongada.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
CA2409292A1 (en) Tablets and methods for modified release of hydrophilic and other active agents
ATE217789T1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
ATE239456T1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
ATE290854T1 (de) Carbamazepinformulierung mit verzögerter freigabe
SE9704400D0 (sv) Porous inorganic particles as carriers for drug substances
DE68905613D1 (de) Pharmazeutische zubereitung.
DE69827466D1 (de) Geschmacksneutrale pharmazeutische zusammensetzungen
WO2002028424A3 (en) Kyberdrug as autovaccines with immune-regulating effects
ID20967A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
CO4750645A1 (es) Metodo de preparacion de granulos que incorporan un medica- mento para uso farmaceutico
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
DE60001717D1 (de) Mikrokapseln mit verzögerter freisetzung von wirkstoffen
ATE376827T1 (de) Solid darreichungsform enthaltend koffein
KR910019608A (ko) 미감 차폐 및 서방성 약제용 피복물
TH61593B (th) สารผสมที่มีเตตราไฮโดรลิพสตาติน
RU99107944A (ru) Лечебное средство прямого антикоагулянтного и фибринолитического действия

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties